Cerebral microbleeds and acute myocardial infarction: Screening and disease progression.

ABSTRACT:

Introduction

Cerebral microbleeds (CMB) are associated with intracerebral haemorrhage. Therefore they may represent a concern if anticoagulant and/or antiplatelet therapy is needed. The aim of this study was to determine the prevalence of CMB in patients with acute myocardial infarction (AMI), and to follow their progression at 3 months under dual antiplatelet therapy (DAPT).

Methods

This prospective study included patients aged over 60 hospitalized in intensive cardiac care unit in our city for AMI. These patients underwent a first brain Magnetic resonance imaging (MRI) within 72 h of admission, that was repeated 3 months.

Results

108 patients were included between November 2016 and December 2018. The prevalence of CMB was 21.3%, with a female predominance of 65.2% v

SUBMITTER: Alaa El Din A 

PROVIDER: S-EPMC7262454 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature